188 related articles for article (PubMed ID: 29112230)
1. Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Zheng DJ; Lu X; Schore RJ; Balsamo L; Devidas M; Winick NJ; Raetz EA; Loh ML; Carroll WL; Sung L; Hunger SP; Angiolillo AL; Kadan-Lottick NS
Cancer; 2018 Feb; 124(3):571-579. PubMed ID: 29112230
[TBL] [Abstract][Full Text] [Related]
2. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of anxiety and depression after completion of chemotherapy for childhood acute lymphoblastic leukemia: A prospective longitudinal study.
Kunin-Batson AS; Lu X; Balsamo L; Graber K; Devidas M; Hunger SP; Carroll WL; Winick NJ; Mattano LA; Maloney KW; Kadan-Lottick NS
Cancer; 2016 May; 122(10):1608-17. PubMed ID: 27028090
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Myers RM; Balsamo L; Lu X; Devidas M; Hunger SP; Carroll WL; Winick NJ; Maloney KW; Kadan-Lottick NS
Cancer; 2014 May; 120(9):1417-25. PubMed ID: 24473774
[TBL] [Abstract][Full Text] [Related]
5. Quality of life during active treatment for pediatric acute lymphoblastic leukemia.
Sung L; Yanofsky R; Klaassen RJ; Dix D; Pritchard S; Winick N; Alexander S; Klassen A
Int J Cancer; 2011 Mar; 128(5):1213-20. PubMed ID: 20473921
[TBL] [Abstract][Full Text] [Related]
6. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
7. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
Kunin-Batson A; Kadan-Lottick N; Neglia JP
Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands.
Schwartz ER; Rensen N; Steur LMH; Gemke R; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; Kaspers GJL; Van Litsenburg RRL
BMJ Open; 2023 Oct; 13(10):e070804. PubMed ID: 37899146
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life of children with acute lymphoblastic leukaemia: comparisons and correlations between parent and clinician reports.
Waters EB; Wake MA; Hesketh KD; Ashley DM; Smibert E
Int J Cancer; 2003 Feb; 103(4):514-8. PubMed ID: 12478668
[TBL] [Abstract][Full Text] [Related]
11. Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG; Flamand Y; Stevenson KE; Neuberg DS; Athale UH; Kelly KM; Laverdiere C; Michon B; Place AE; Sallan SE; Silverman LB; Vrooman LM
Pediatr Blood Cancer; 2023 Nov; 70(11):e30560. PubMed ID: 37461125
[TBL] [Abstract][Full Text] [Related]
12. Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group report.
Lau S; Lu X; Balsamo L; Devidas M; Winick N; Hunger SP; Carroll W; Stork L; Maloney K; Kadan-Lottick N
Pediatr Blood Cancer; 2014 Dec; 61(12):2277-84. PubMed ID: 25175168
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in children with acute lymphoblastic leukaemia.
Jankowska-Polańska B; Sliwiński M; Świątoniowska N; Butrym A; Mazur G
Scand J Caring Sci; 2020 Jun; 34(2):380-389. PubMed ID: 31334869
[TBL] [Abstract][Full Text] [Related]
14. Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
Rodwin RL; Kairalla JA; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Angiolillo AL; Ness KK; Kadan-Lottick NS
J Natl Cancer Inst; 2022 Aug; 114(8):1167-1175. PubMed ID: 35552709
[TBL] [Abstract][Full Text] [Related]
15. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Japanese children with acute lymphoblastic leukemia during and after chemotherapy.
Kobayashi K; Nakagami-Yamaguchi E; Hayakawa A; Adachi S; Hara J; Tokimasa S; Ohta H; Hashii Y; Rikiishi T; Sawada M; Kuriyama K; Kohdera U; Kamibeppu K; Kawasaki H; Oda M; Hori H
Pediatr Int; 2017 Feb; 59(2):145-153. PubMed ID: 27422759
[TBL] [Abstract][Full Text] [Related]
17. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract][Full Text] [Related]
18. Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia.
van Litsenburg RR; Huisman J; Pieters R; Verhaak C; Kaspers GJ; Gemke RJ
Support Care Cancer; 2014 Dec; 22(12):3235-42. PubMed ID: 25011520
[TBL] [Abstract][Full Text] [Related]
19. The Health Initiative Program for Kids (HIP Kids): effects of a 1-year multidisciplinary lifestyle intervention on adiposity and quality of life in obese children and adolescents--a longitudinal pilot intervention study.
Bock DE; Robinson T; Seabrook JA; Rombeek M; Norozi K; Filler G; Rauch R; Clarson CL
BMC Pediatr; 2014 Dec; 14():296. PubMed ID: 25475951
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.
Kantarjian HM; Su Y; Jabbour EJ; Bhattacharyya H; Yan E; Cappelleri JC; Marks DI
Cancer; 2018 May; 124(10):2151-2160. PubMed ID: 29508899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
